Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Interest Expenses (2023 - 2025)

Historic Interest Expenses for Biofrontera (BFRI) over the last 3 years, with Q1 2025 value amounting to $120000.0.

  • Biofrontera's Interest Expenses fell 9155.52% to $120000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $175000.0, marking a year-over-year decrease of 8887.48%. This contributed to the annual value of $2.1 million for FY2024, which is 85727.27% up from last year.
  • According to the latest figures from Q1 2025, Biofrontera's Interest Expenses is $120000.0, which was down 9155.52% from $55000.0 recorded in Q4 2024.
  • In the past 5 years, Biofrontera's Interest Expenses ranged from a high of $1.4 million in Q1 2024 and a low of $9000.0 during Q3 2024
  • In the last 3 years, Biofrontera's Interest Expenses had a median value of $87500.0 in 2024 and averaged $298500.0.
  • As far as peak fluctuations go, Biofrontera's Interest Expenses crashed by 6153.85% in 2024, and later tumbled by 9155.52% in 2025.
  • Biofrontera's Interest Expenses (Quarter) stood at $143000.0 in 2023, then plummeted by 61.54% to $55000.0 in 2024, then skyrocketed by 118.18% to $120000.0 in 2025.
  • Its Interest Expenses was $120000.0 in Q1 2025, compared to $55000.0 in Q4 2024 and $9000.0 in Q3 2024.